Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine,and melphalan RIC HCT. - Marsh, Rebecca A.; Lane, Adam; Mehta, Parinda A.; Neumeier, Lisa; Jodele, Sonata; Davies, Stella M.; Filipovich, Alexandra H. (Blood, 2016)